Results 31 to 40 of about 16,438 (200)

Ultrasound versus temporal artery biopsy in patients with Giant cell arteritis: a prospective cohort study

BMC Medical Imaging, 2019
Background Diagnosis of giant cell arteritis by temporal artery biopsy is time-consuming and visual loss lies in the first week after its diagnosis. The purpose of the study was to test the hypothesis that ultrasound can reduce the risk of overdiagnosis ...
Quan Zou, Sumei Ma, Xinghu Zhou
doaj   +1 more source

Alternating Transient Monocular Vision Loss Due to Giant Cell Arteritis

Annals of Internal Medicine: Clinical Cases, 2023
Giant cell arteritis is a systemic granulomatous vasculitis commonly involving the temporal artery and associated with visual deficits. The most common ocular presentation of giant cell arteritis involves anterior ischemic ocular neuropathy with sudden ...
Benjamin J. McCormick, Rex K. Siu, Eric Eggenberger, Ronald R. Butendieck, Michael J. Maniaci   +4 more
doaj   +1 more source

Giant Cell Arteritis

Journal of the Belgian Society of Radiology, 2018
Bruno Coulier, Luc Montfort, Isabelle Gielen   +2 more
doaj   +7 more sources

Polymyalgia rheumatica presenting as sternoclavicular arthritis: a case report

Journal of Medical Case Reports, 2022
Background Polymyalgia rheumatica and giant cell arteritis are systemic inflammatory conditions of the elderly. Polymyalgia rheumatica classically presents as a bilateral proximal muscle pain and stiffness syndrome.
Liyana Arachchige Dona Thulini Madubashini, Jayawardane Pathiranage Roneesha Lakmali, Nilanka Perera   +2 more
doaj   +1 more source

Giant Cell Arteritis Presenting With Ocular Symptoms: Clinical Characteristics and Multimodal Imaging in a Chinese Case Series

Frontiers in Medicine, 2022
PurposeTo evaluate demographic and clinical characteristics of a Chinese population with giant cell arteritis using multimodal imaging focusing on ophthalmic examinations.DesignRetrospective observational case series.Materials and MethodsIn the neuro ...
Qian Chen, Weimin Chen, Chaoyi Feng, Deshan Gong, Jiong Zhang, Yingwen Bi, Ping Sun, Xinghuai Sun, Xinghuai Sun, Guohong Tian, Guohong Tian   +10 more
doaj   +1 more source

Large vessel giant cell arteritis [PDF]

Giant cell arteritis is the principal form of systemic vasculitis affecting people over 50. Large-vessel involvement, termed large vessel giant cell arteritis, mainly affects the aorta and its branches, often occurring alongside cranial giant cell ...
van der Geest, Kornelis S.M., Stone, James R., Brouwer, Elisabeth, Sandovici, Maria, Slart, Riemer H.J.A., Bley, Thorsten A.   +5 more
core   +2 more sources

Perceived Impacts and Predictors of Cannabis Products Used by Patients with Rheumatologic Conditions in Alberta, Canada: A Multivariable Analysis of Cross‐Sectional Survey Data

Arthritis Care &Research, EarlyView.
Objective This study aimed to characterize cannabis product choices (cannabinoid content and formulation) among patients with rheumatologic conditions and their associations with patient factors, patient‐reported perceived side effects, and positive impacts.
Susan Zhang, Samuel A.J. Lowe, Frank Sun, Allyson Jones, Tarek Turk, Joanne Olson, Pauline Paul, Shelby Yamamoto, Linda Kolewaski, Elaine Yacyshyn, Cheryl A. Sadowski   +10 more
wiley   +1 more source

Coexistence of giant cell arteritis and subacute thyroiditis: A case report and literature review

Journal of International Medical Research
Giant cell arteritis and subacute thyroiditis are often regarded as clinically distinct diseases with differing pathogenesis. We report a rare case of coexisting giant cell arteritis and subacute thyroiditis that were both successfully managed using ...
Cheng Xu, Yongmei Han
doaj   +1 more source

Giant Cell Arteritis: A review of current knowledge and new biological treatment options

Journal of Education, Health and Sport
Introduction and objective  Giant cell arteritis (GCA) is the most common primary systemic vasculitis in Europe. It mainly affects individuals over the age of fifty, its incidence increases with age. The most common clinical manifestation is bilateral
Aleksandra Cygnarowicz
doaj   +1 more source

Prescribing of Medication to Prevent Glucocorticoid Harms in Patients With Polymyalgia Rheumatica: A Cross‐Sectional Study and Two Emulated Target Trials in the Clinical Practice Research Datalink Aurum

Arthritis &Rheumatology, EarlyView.
Objective Polymyalgia rheumatica (PMR) is a common indication for long‐term glucocorticoid (GC) treatment. Bone‐protective and gastroprotective medications are recommended for those at high risk of adverse events from GCs, but no trials have evaluated their effectiveness in PMR.
Helen Twohig, David Jenkinson, James Bailey, Samantha Hider, Ian C. Scott, Sara Muller   +5 more
wiley   +1 more source